University of Cagliari
Cagliari, Italy
NCT Number: NCT04839913
The investigator analyzed the data of the patients admitted to the surgical department during the period 1St September - 10Th December 2020 to estimate the seroprevalence of SARS-CoV-2 infection in the setting of a non-dedicated COVID-19 hospital and in a mild CoV-2 incidence area and to evaluate the difference of seroprevalence between Spring and Fall seasons in a cohort of patients undergoing surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Cagliari, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Serologic test for both SARS-COV-2 IgG and IgM
Time frame: 1St September - 10Th December 2020
SARS-COV-2 IgG and IgM seroprevalence between spring and fall period
University of Cagliari
Other
Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Update From an Unicentric, Regional Study
Acronym: COVID-19
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04510194
COVID-19, Coronaviridae Infections
Sylmar, California, United States
View Trial DetailsNCT04895475
COVID-19, Coronaviridae Infections
Cincinnati, Ohio, United States
View Trial DetailsNCT04885452
COVID-19, Coronaviridae Infections
Agen, France
View Trial DetailsNCT04865237
COVID-19, Corona Virus Infection
London, United Kingdom
View Trial Details